Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Extensive Stage Lung Small Cell Carcinoma × lipoarabinomannan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Extensive Stage Lung Small Cell Carcinoma 1

Interventions

Etoposide 2 Carboplatin 2 olaparib 1 lipoarabinomannan 1 cediranib 1 atezolizumab 1 Platinum 1 Lamivudine 1 Cisplatin 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04696575 2025-12-15

Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer

Roswell Park Cancer Institute

Phase 2 Recruiting

Extensive Stage Lung Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡